XML 84 R18.htm IDEA: XBRL DOCUMENT v3.25.1
Stock Options and Restricted Stock Units
12 Months Ended
Dec. 31, 2024
Stock Options and Restricted Stock Units  
Stock Options and Restricted Stock Units

Note 9: Stock Options and Restricted Stock Units

 

On June 7, 2023, the shareholders of the Company approved the 2023 Equity Incentive Plan (the “2023 Plan”).  Under the terms of the 2023 Plan, the Company is authorized to issue incentive awards for common stock up to 300,000 shares to employees and other personnel. The awards may be in the form of incentive stock options, nonqualified stock options, restricted stock, restricted stock units and performance awards. The 2023 Plan is effective through April 1, 2033. As of December 31, 2024, there are 365,078 shares which remain to be granted under the 2023 Plan, including 122,076 shares assumed under the Company’s previous 2014 Equity Incentive Plan, as amended.

 

The following is a summary of stock options issued during the year ended December 31, 2024 and 2023:

 

 

 

Number of Options

Outstanding

 

 

Range of

Exercise Price

 

 

Weighted Average

Exercise Price

 

 

Aggregate

Intrinsic Value

 

Balance on December 31, 2022

 

 

81,250

 

 

$

  6.80 – 27.71

 

 

$20.17

 

 

$462,390

 

Options granted

 

 

30,000

 

 

 

26.98

 

 

 

26.98

 

 

 

 

Options exercised

 

 

(2,500 )

 

 

7.76

 

 

 

7.76

 

 

 

19,400

 

Options forfeited/cancelled

 

 

(2,000 )

 

9.26 – 27.71

 

 

 

23.10

 

 

 

 

Balance on December 31, 2023

 

 

106,750

 

 

$

  6.80 – 27.71

 

 

$22.32

 

 

$176,360

 

Options granted

 

 

 

 

 

 

 

 

 

 

 

 

Options exercised

 

 

 

 

 

 

 

 

 

 

 

 

Options forfeited/cancelled

 

 

(47,000 )

 

9.26 – 26.00

 

 

 

21.97

 

 

 

 

Balance on December 31, 2024

 

 

59,750

 

 

$

 6.80 – 27.71

 

 

$22.60

 

 

 

10,700

 

The aggregate intrinsic value in the table above represents the total pretax intrinsic value (i.e. the aggregate difference between the closing price of the Company’s common stock on December 31, 2024 and 2023 of $8.94 and $18.13, respectively, and the exercise price for in-the-money options) that would have been received by the holders if all instruments had been exercised on December 31, 2024 and 2023. As of December 31, 2024, there was $208,000 of unrecognized compensation cost related to stock options, which will be recognized through 2027.

 

The following is a summary of unvested stock options during the year ended December 31, 2024 and 2023:

 

 

 

Number of Options

Outstanding

 

 

Weighted Average

Exercise Price

 

 

Weighted Average Grant Date Fair Value

 

Balance on December 31, 2022

 

 

44,250

 

 

$26.55

 

 

$12.41

 

Options granted

 

 

30,000

 

 

 

26.98

 

 

 

13.89

 

Options vested

 

 

(7,500 )

 

 

27.71

 

 

 

13.53

 

Options forfeited/cancelled

 

 

(1,500 )

 

 

26.00

 

 

 

11.87

 

Balance on December 31, 2023

 

 

65,250

 

 

 

26.78

 

 

 

13.12

 

Options granted

 

 

 

 

 

 

 

 

 

Options vested

 

 

(27,750 )

 

 

27.05

 

 

 

13.18

 

Options forfeited/cancelled

 

 

(15,000 )

 

 

26.00

 

 

 

11.87

 

Balance on December 31, 2024

 

 

22,500

 

 

 

26.98

 

 

 

13.89

 

 

The following table summarizes information about stock options outstanding and exercisable on December 31, 2024: 

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Exercise Price Range

 

Number

 

 

Weighted Average Remaining Contractual Life (in Years)

 

 

Weighted Average

Exercise Price

 

 

Number

 

$0.01 - 8.00 

 

 

5,000

 

 

 

0.89

 

 

 

6.80

 

 

 

5,000

 

$8.01 - 11.00 

 

 

2,000

 

 

 

4.50

 

 

 

10.75

 

 

 

2,000

 

$11.01 - 16.00 

 

 

10,000

 

 

 

4.16

 

 

 

13.21

 

 

 

10,000

 

$16.01 - 27.00 

 

 

30,000

 

 

 

8.01

 

 

 

26.98

 

 

 

7,500

 

$27.01 – 27.71 

 

 

12,750

 

 

 

7.05

 

 

 

27.71

 

 

 

12,750

 

Total 

 

 

59,750

 

 

 

6.45

 

 

 

22.60

 

 

 

37,250

 

 

Of the 59,750 stock options outstanding, 20,926 are non-qualified stock options. All options have been registered with the SEC. 

The following is a summary of restricted stock units issued during the years ended December 31, 2024 and 2023:

 

 

 

Number of RSUs Outstanding

 

 

Weighted Average

Grant Date

Fair Value

 

 

Aggregate

Intrinsic Value

 

Balance on December 31, 2022

 

 

50,740

 

 

$25.00

 

 

$1,268,500

 

Units granted

 

 

74,832

 

 

 

26.08

 

 

 

1,951,619

 

Units vested/issued

 

 

(21,490 )

 

 

25.24

 

 

 

(542,408 )

Units forfeited

 

 

(9,250 )

 

 

23.87

 

 

 

(220,798 )

Balance on December 31, 2023

 

 

94,832

 

 

$25.90

 

 

$2,456,149

 

Units granted

 

 

43,666

 

 

 

12.41

 

 

 

541,932

 

Units vested/issued

 

 

(18,999 )

 

 

20.26

 

 

 

(384,830 )

Units forfeited

 

 

(24,333 )

 

 

25.85

 

 

 

(628,984 )

Balance on December 31, 2024

 

 

95,166

 

 

 

20.85

 

 

 

1,984,267

 

 

During the year ended December 31, 2024, the Company granted 43,666 shares of restricted stock units to employees, contractors and the Board of Directors, which vest at various intervals over the next 3 years. The average grant date fair value of these grants was $12.41 per share during the year ended December 31, 2024. During the year ended December 31, 2024, 18,999 restricted stock units with a grant date average intrinsic value of $20.26 per share, vested. As of December 31, 2024, there was $830,000 of unrecognized compensation cost related to our unvested restricted stock units, which will be recognized through 2027.

 

During the years ended December 31, 2024 and 2023, the Company recorded compensation expense of $684,000 and $1,365,000, respectively, related to stock options and restricted stock units.